Home/ Stocks/ ACLX

Arcellx, Inc. Common Stock

ACLX XNAS

$114.81 +0.02 (+0.01%) ▲ 15-min delayed

Open

$114.78

High

$114.83

Low

$114.78

Volume

191.7K

Market Cap

$6.71B

About Arcellx, Inc. Common Stock

Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.

Sector: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Employees: 209 Website →

Key Financials

Period	Revenue	Net Income	EPS
TTM 2025	$22.29M	$-228,934,000	$-4.07
FY 2025	$22.29M	$-228,934,000	$-4.07
Q3 2025	$4.95M	$-55,781,000	$-0.99
Q2 2025	$7.55M	$-52,771,000	$-0.94

TickerDaily Coverage

Why Is Arcellx, Inc. Common Stock (ACLX) Stock Up 77.4% Today?

Market News Alex Chen · Feb 24, 2026

Arcellx stock exploded 77.4% to $113.75 on a massive 32.9M-share volume surge after Gilead Sciences...

Why Is Arcellx, Inc. Common Stock (ACLX) Stock Up 77.7% Today?

Market News Alex Chen · Feb 23, 2026

Arcellx stock exploded 77.7% today after Gilead Sciences announced it would acquire the...

Why Is Arcellx, Inc. Common Stock (ACLX) Stock Up 78.1% Today?

Market News Sarah Mitchell · Feb 23, 2026

Arcellx stock exploded 78.1% higher to $64.11 on heavy volume as the CAR T-cell therapy sector...

View All Coverage →

Get ACLX Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Arcellx, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.